Skip to main content
HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.670
+0.050 (1.90%)
Nov 22, 2024, 4:00 PM EST - Market closed

HeartSciences Revenue

HeartSciences had revenue of $18.60K in the twelve months ending July 31, 2024, up 853.85% year-over-year. In the fiscal year ending April 30, 2024, HeartSciences had annual revenue of $18.60K with 261.17% growth.

Revenue (ttm)
$18.60K
Revenue Growth
+853.85%
P/S Ratio
74.81
Revenue / Employee
$1,240
Employees
15
Market Cap
2.44M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 202418.60K13.45K261.17%
Apr 30, 20235.15K-9.22K-64.17%
Apr 30, 202214.37K-11.23K-43.86%
Apr 30, 202125.60K-38.58K-60.11%
Apr 30, 202064.18K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xylo Technologies 57.64M
Nuwellis 8.97M
ReShape Lifesciences 8.18M
Avinger 7.26M
Petros Pharmaceuticals 4.02M
NanoVibronix 3.29M
Biodexa Pharmaceuticals 104.90K
Revenue Rankings

HSCS News

More News